" class="no-js "lang="en-US"> WHO Chooses MedicAir to Tackle ‘Invisible Threat’ in Hospitals
Wednesday, June 19, 2024

The World Health Organisation chooses British air purification company, MedicAir, to tackle ‘invisible threat’ in hospitals

British air purification company, MedicAir, has beaten international firms to be awarded a year-long contract by the World Health Organisation (WHO) to deliver air purification in 55 hospitals in Mauritius.

“We are immensely proud, as a British company, to be supplying MedicAir to the World Health Organisation,” says Dr. Matthew Perkins, Managing Director of MedicAir. “Following a long tendering process against many international competitors, this choice reflects the quality and technology that make MedicAir unique.”

While most associate hospitals with treating diseases and serious conditions, these environments are high risk, posing health problems of their own brought on by a complex cocktail of poor ventilation, higher density of people with health conditions, and polluted air coming in from outside. As such, the indoor air quality (IAQ) of many hospitals often contains a higher-level concentration of airborne pollutants and pathogens, compared to other enclosed spaces. Bacteria, germs, and viruses, as well as cleaning chemicals and other irritants used in medical practices and procedures, are the ‘invisible threats’ that can adversely impact the health of patients in healthcare settings. If left unchecked, airborne hazards can easily spread between wards aggravating existing conditions, worsening serious illnesses, increasing new infections and, in some scenarios, leading to deaths.

In 2021, the World Health Organisation recommended air purifiers to supplement integrated ventilation systems in hospitals around the world to combat SARS-CoV-2 transmission. Beyond Covid, the need to improve indoor air quality within healthcare settings worldwide remains critical.

MedicAir supplies medical-grade air purifiers that combine hospital-grade air filtration, activated carbon filtration, and virus-killing UVC technologies in a simple unit that is plugged in and provides instant protection with no professional installation. MedicAir is found in thousands of NHS hospitals, schools, care homes, and businesses throughout the UK, Europe and North America. MedicAir’s appointment by the World Health Organisation to help Mauritius hospitals meet the WHO’s own legal limits for PM2.5. (one of the most dangerous air pollutants), is a major coup for the British based business.

Dr. Perkins concludes: “It shows MedicAir’s unique air purification technology is one of the best in the market – and can be trusted by healthcare providers across the globe to ensure that patients, doctors, nurses and GPs don’t breathe dirty air.”

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more